Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Dec 8;117(49):30896-30897.
doi: 10.1073/pnas.2009961117. Epub 2020 Nov 17.

Does tocilizumab have a magical therapeutic effect on COVID-19 patients without obvious adverse reactions?

Yong Wang  1   2 , Qing Mao  3   4 , Xiangdong Zhou  5   6
Affiliations
Comment

Does tocilizumab have a magical therapeutic effect on COVID-19 patients without obvious adverse reactions?

Yong Wang et al. Proc Natl Acad Sci U S A. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interest.

Comment in

Comment on

  • Effective treatment of severe COVID-19 patients with tocilizumab.
    Xu X, Han M, Li T, Sun W, Wang D, Fu B, Zhou Y, Zheng X, Yang Y, Li X, Zhang X, Pan A, Wei H. Xu X, et al. Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975. doi: 10.1073/pnas.2005615117. Epub 2020 Apr 29. Proc Natl Acad Sci U S A. 2020. PMID: 32350134 Free PMC article.

References

    1. Huang C. et al. ., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497–506 (2020). - PMC - PubMed
    1. Yang X. et al. ., Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. Lancet Respir. Med. 8, 475–481 (2020). - PMC - PubMed
    1. Xu X. et al. ., Effective treatment of severe COVID-19 patients with tocilizumab. Proc. Natl. Acad. Sci. U.S.A. 117, 10970–10975 (2020). - PMC - PubMed
    1. The National Health Commission of the People's Republic of China, Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Seventh Interim Edition). http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb19.... Accessed 3 March 2020.
    1. Luo P. et al. ., Tocilizumab treatment in COVID-19: A single center experience. J. Med. Virol. 92, 814–818 (2020). - PMC - PubMed

Substances

LinkOut - more resources